We are live on ! Find out more
CP

Castleview Partners Portfolio holdings

AUM $228M
1-Year Est. Return 19.85%
This Fund
S&P 500
This Quarter Est. Return
+1.46%
1 Year Est. Return
+19.85%
3 Year Est. Return
+54.5%
5 Year Est. Return
10 Year Est. Return
AUM
$176M
AUM Growth
-$3.18M
Cap. Flow
-$4.81M
Cap. Flow %
-2.74%
Top 10 Hldgs %
30.76%
Holding
1,016
New
119
Increased
248
Reduced
247
Closed
101

Sector Composition

Rank Sector Weight
1 Technology 9.2%
2 Consumer Discretionary 6.91%
3 Financials 5.97%
4 Healthcare 5.35%
5 Consumer Staples 2.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
101
Meta Platforms (Facebook)
META
$1.51T
$407K 0.23%
807
+201
+33% +$97.7K
EPD icon
102
Enterprise Products Partners
EPD
$83.6B
$406K 0.23%
14,000
-187
-1% -$5.36K
BITB icon
103
Bitwise Bitcoin ETF
BITB
$2.45B
$404K 0.23%
12,362
-27,992
-69% -$1M
BILS icon
104
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
$3.89B
$403K 0.23%
4,051
-251
-6% -$24.9K
MCO icon
105
Moody's
MCO
$83.9B
$402K 0.23%
954
-11
-1% -$4.38K
BAX icon
106
Baxter International
BAX
$12.6B
$386K 0.22%
11,553
+7,195
+165% +$265K
STRA icon
107
Strategic Education
STRA
$1.84B
$383K 0.22%
3,457
+247
+8% +$27.3K
TSLA icon
108
Tesla
TSLA
$1.21T
$382K 0.22%
1,929
-68
-3% -$11.9K
SSO icon
109
ProShares Ultra S&P500
SSO
$7.75B
$379K 0.22%
9,178
-12,956
-59% -$498K
JNJ icon
110
Johnson & Johnson
JNJ
$643B
$377K 0.21%
2,578
+102
+4% +$15.2K
FISV
111
Fiserv Inc
FISV
$28.9B
$370K 0.21%
2,484
+955
+62% +$145K
PEP icon
112
PepsiCo
PEP
$195B
$364K 0.21%
2,206
+7
+0.3% +$1.21K
NVO
113
Novo Nordisk
NVO
$225B
$363K 0.21%
2,544
+99
+4% +$13.1K
CVX icon
114
Chevron
CVX
$374B
$360K 0.2%
2,299
+221
+11% +$35.2K
TFI icon
115
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.06B
$355K 0.2%
7,754
-241
-3% -$11K
BNDX icon
116
Vanguard Total International Bond ETF
BNDX
$82.3B
$348K 0.2%
7,143
-17,912
-71% -$872K
PECO icon
117
Phillips Edison & Co
PECO
$5.48B
$346K 0.2%
10,588
-4,563
-30% -$149K
PGR icon
118
Progressive
PGR
$128B
$346K 0.2%
1,667
-542
-25% -$113K
AGNC icon
119
AGNC Investment
AGNC
$12.9B
$339K 0.19%
35,534
-89
-0.2% -$852
CAT icon
120
Caterpillar
CAT
$387B
$335K 0.19%
1,006
-101
-9% -$35K
IHI icon
121
iShares US Medical Devices ETF
IHI
$3.14B
$335K 0.19%
5,976
+313
+6% +$17.5K
PSLV icon
122
Sprott Physical Silver Trust
PSLV
$11.7B
$332K 0.19%
33,477
-2,809
-8% -$27.3K
PAVE icon
123
Global X US Infrastructure Development ETF
PAVE
$14.1B
$328K 0.19%
8,862
+6,258
+240% +$239K
DDM icon
124
ProShares Ultra Dow30
DDM
$548M
$324K 0.18%
7,818
+2,798
+56% +$115K
ITA icon
125
iShares US Aerospace & Defense ETF
ITA
$14.5B
$324K 0.18%
2,450
-388
-14% -$51.4K

Similar funds

Castleview Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Castleview Partners held 1,016 positions worth $176M, down 1.8% from $179M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Castleview Partners's Q2 2024 filing shows 119 new, 248 increased, 247 reduced and 101 closed positions. Its largest new stake was FT Vest US Equity Buffer & Premium Income ETF March: 24,884 shares worth $777K. The largest sale was Regan Floating Rate MBS ETF, an estimated $2.28M.

By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 8.5% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Castleview Partners's largest Q2 2024 buy was FT Vest US Equity Buffer & Premium Income ETF March: 24,884 shares worth $777K.
  • Castleview Partners added most to Alpha Architect 1-3 Month Box ETF in Q2 2024, an estimated $1.3M increase.
  • Castleview Partners's biggest Q2 2024 reduction was Regan Floating Rate MBS ETF, cutting an estimated $2.28M.
  • Castleview Partners fully exited Invesco BulletShares 2024 Corporate Bond ETF in Q2 2024, selling an estimated $1.2M.
  • Castleview Partners's ten largest holdings make up 31% of its $176M portfolio in Q2 2024.
  • Castleview Partners opened 119 new positions and closed 101 in Q2 2024.
  • Castleview Partners's portfolio value fell 1.8% quarter-over-quarter to $176M.

Based on Castleview Partners's 13F filing for Q2 2024, filed 31 Jul 2024.